| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |